Breaking News
March 25, 2019 - CPAP treatment can result in weight loss in people with sleep apnea and obseity
March 25, 2019 - Breast Density Categorization Varies With Screening Modality
March 25, 2019 - Researchers explore link between metal exposure and Parkinson’s symptoms
March 25, 2019 - Around one in hundred people has autism spectrum condition in China
March 25, 2019 - Research paves way for new standard of care to improve heart’s pump function
March 25, 2019 - Exposure to HIV virus, antiretroviral therapy before birth linked to obesity and asthma-like symptoms
March 25, 2019 - Transgender men preserve their fertility potential after one year of testosterone therapy
March 25, 2019 - Tighter Blood Pressure Control May Prevent Brain Lesions
March 25, 2019 - A reward now or later? Exploring impulsivity in Parkinson’s disease patients
March 25, 2019 - Financial incentives fail to increase completion rates of colorectal cancer screening tests mailed to patients
March 25, 2019 - New research program launched to highlight sexual harassment in academia
March 25, 2019 - Hemoglobin A1c blood test does not detect diabetes in most patients, shows study
March 25, 2019 - Wyss Technology licensed by Sherlock Biosciences to create affordable molecular diagnostics
March 25, 2019 - DWK Life Sciences launches KIMBLE GLS 80 Media Bottle and Multiport Cap System
March 25, 2019 - New study aims to reduce online sexual exploitation of children
March 25, 2019 - Want healthier eating habits? Start with a workout
March 25, 2019 - New approach to prescribing antibiotics could curb resistance
March 24, 2019 - Theravance Biopharma Announces First Patient Dosed in Phase 2b/3 Study of TD-1473 in Patients with Ulcerative Colitis
March 24, 2019 - Prenatal DHA prevents blood-pressure increase from obesity during childhood
March 24, 2019 - Combined immunosuppression may be effective, safe in treating older patients with Crohn’s disease
March 24, 2019 - GSK sells health drinks arm, buys US cancer treatment firm
March 24, 2019 - Bacteria and innate immune factors in birth canal, cervix may be key to predicting preterm births
March 24, 2019 - IgG antibodies play unexpected role in atherosclerosis
March 24, 2019 - Sounds and vibrations are quite similar for the brain, finds new study
March 24, 2019 - Practices for Reducing COPD Hospital Readmissions Explored
March 24, 2019 - Could an eye doctor diagnose Alzheimer’s before you have symptoms?
March 24, 2019 - Enzyme inhibitor stops inflammation and neurodevelopmental disorders in mouse models
March 24, 2019 - Walk, Dance, Clean: Even a Little Activity Helps You Live Longer
March 24, 2019 - Americans used less eye care in 2014 versus 2008
March 24, 2019 - Study finds link between depression in 20s linked to memory loss in 50s
March 24, 2019 - New tool helps physiotherapy students to master complex fine motor skills
March 24, 2019 - The AMR Centre secures £2.3m funding boost
March 24, 2019 - Study examines effects of taking ondansetron during first trimester of pregnancy
March 24, 2019 - Researchers identify a more effective treatment for cancer
March 24, 2019 - Open-source solution for multiparametric optical mapping of the heart’s electrical activity
March 24, 2019 - New nanotechnology approach shows promise in treating triple negative breast cancer
March 24, 2019 - Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute Pain
March 24, 2019 - Maternal deaths following C-section 50 times higher in Africa compared to high-income countries
March 24, 2019 - Apple watch could detect irregular heart beat says study
March 24, 2019 - Queen Mary University of London’s BCI boosts radionuclide imaging capabilities with MILabs VECTor technology
March 24, 2019 - Girls should be encouraged to gain more ball skills, shows study
March 24, 2019 - Acute doses of synthetic cannabinoid can impair critical thinking and memory
March 24, 2019 - Presence of bacteria in urine does not always point to infection, shows study
March 24, 2019 - Scientists identify a new role for nerve-supporting cells
March 24, 2019 - Hidden differences between pathology of CTE and Alzheimer’s disease discovered
March 24, 2019 - Knowing causative genes of osteoporosis may open door to more effective treatments
March 24, 2019 - Toilet-seat based cardiovascular monitoring system getting ready to begin commercialization
March 24, 2019 - New model for intensive care identifies factors that send ill patients to ICU
March 24, 2019 - Recommendations Issued for HSCT in Multiple Myeloma
March 24, 2019 - Deep brain stimulation provides sustained relief for severe depression
March 24, 2019 - “Statistical significance” may soon be a thing of past?
March 24, 2019 - Researchers track effects of epigenetic marks carried by sperm chromosomes
March 24, 2019 - AHA News: Family Adopts Three Children With Three Different Heart Conditions
March 24, 2019 - Research into opioid painkillers could provide clues for safer drug development
March 23, 2019 - Lung cancer survivor recounts her lifetime struggles
March 23, 2019 - Radial and femoral approach for PCI achieve similar results in terms of survival
March 23, 2019 - Study sheds light on the optimal timing of coronary angiography in NSTEMI patients
March 23, 2019 - Excess hormones could cause a condition that can lead to blindness in women, study finds
March 23, 2019 - Dramatic shifts in first-time opioid prescriptions bring hope, concern
March 23, 2019 - Antidepressant drugs may not work when neurons are out of shape
March 23, 2019 - TTUHSC El Paso to establish endowed chair in neurology through a major grant
March 23, 2019 - New device approved by FDA for treating patients with moderate-to-severe heart failure
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
Facial Scarring Improved with Botulinum Toxin

Facial Scarring Improved with Botulinum Toxin

image_pdfDownload PDFimage_print

Action Points

  • Note that this small randomized trial suggested that botulinum toxin may be superior to placebo for reducing certain scar characteristics after a laceration closure.
  • Be aware that the primary outcome, score on the Vancouver Scar Scale, was not significantly different between the two groups, but this may be due to the small sample size for comparison.

Intradermal injection of botulinum toxin type A (Botox) immediately following wound closure improved the appearance of facial surgical scars compared with control scars in a small, randomized, double-blind trial from the People’s Republic of China.

At 6 months’ follow-up, the half of each facial scar treated with the injections following wound closure was narrower and flatter than the half left untreated, Li Hu, MD, PhD, and colleagues from the Shanghai Jiao Tong University School of Medicine Shanghai, reported in Plastic and Reconstructive Surgery.

The mean Vancouver Scar Scale score, used to characterize hypertrophic scars, was also lower for the half of the scar that was treated with the toxin, at 4.68 compared with 5.24 for the half that was not treated, although this difference was not statistically significant (P=0.146), the investigators added.

“Too many reports have focused on the treatment rather than the prevention of untoward surgical scars. However, early management of surgical scars is more likely to yield a better cosmetic appearance and require fewer treatments. This study demonstrates that early postsurgical botulinum toxin injections can produce better, narrower, and flatter facial surgical scars [than scars that remain untreated].”

For the study, 16 patients were randomized to receive botulinum toxin type A injections to half of their facial scar and the other half of the scar was treated with 0.9% normal saline.

“Immediately after skin closure, the encoded vial contents (0.2 mL containing 10 U for each 1-cm scar) were injected at a distance of 5 mm on either side of the wound,” the team wrote. The mean amount of botulinum toxin injected per scar was 33.7 U (range, 15 to 80 U). The mean age of the subjects was 12 (range, 6 to 49), while the mean length of the scar was 6.74 cm (range, 3 to 16 cm). The original diagnoses included congenital melanocytic nevi, port-wine stains, arteriovenous malformations, and disfiguring scars. Fourteen of the 16 patients completed the study.

In a subset analysis, the difference in the Vancouver Scar Scale height score at 6 months was significantly lower, at 0.47 for the treated part of the scar compared with 0.76 for the half that was not treated (P=0.009). At the same time point, the treated portion of the scar was also significantly narrower at 0.32, compared with 0.43 (P=0.001) for the untreated segment of the scar. The mean visual analogue scale (VAS) score was also higher at 5.76 for the treated part of the scar, compared with 4.97 for the control side — a difference between the two sides that was again significant (P=0.046).

In contrast, no significant differences were seen in the subdomains of pigmentation at 1.63 for the treated side versus 1.58 for the control side (P=0.391) or in vascularity, at 1.24 for the treated side versus 1.32 for the control side (P=0.263). No adverse events were noted. Tension at the edges of a wound significantly contributes to unsightly scars, the researchers explained.

“Temporary muscular paralysis induced by botulinum toxin type A could decrease movement and stress around a healing wound. This relief of tension may help prevent facial scar widening, hypertrophy, and hyperpigmentation.”

The authors also noted that botulinum toxin may have a direct inhibitory effect on fibroblasts and transforming growth factor-β1 expression, both key to the development of hypertrophic scars. A previously published study similarly found that early injections of the same botulinum toxin improved the appearance of facial scars — again by inducing temporary muscle paralysis and decreasing tension on wound edges.

Asked for her opinion, Tina Alster, MD, director of the Washington Institute of Dermatologic Laser Surgery in Washington, D.C., who was not involved with the study, pointed out that one of the limitations was the small sample size. She also noted that in general, scars on the face and neck tend to heal fairly well, as they are not under a lot of tension, which can contribute to unsightly scars.

However, she said she agreed in principle that starting early to try and minimize scars is a good idea: “I do a lot of laser scar revision and even using lasers to reverse red or hypertrophic keloid scars, we found that the earlier you start using the laser, the less severe the scar, and the earlier the scar looks better.”

In addition, Alster said, for many practitioners, incorporating the use of botulinum toxin into the practice of scar management is likely to be more readily available than the use of lasers, although in her own practice, she has found it actually to be less expensive and even less invasive to use a laser for scar revision than to inject botulinum toxin around a wound.

“I think it’s an important study if only because it asks the question, will the use of Botox or any of the other neuromodulators reduce scar formation by directly reducing the mechanical forces across a wound bed, and that answer is likely yes.”

“So in general this is a ‘thumbs up’ study, but with the caveat that larger studies of more significant scars are still warranted.”

The study authors, as well as Alster, reported having no financial conflicts of interest.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-03-13T12:00:00-0400

Tagged with:

About author

Related Articles